vs
Esperion Therapeutics, Inc.（ESPR）与FARMER BROTHERS CO（FARM）财务数据对比。点击上方公司名可切换其他公司
Esperion Therapeutics, Inc.的季度营收约是FARMER BROTHERS CO的1.9倍（$168.4M vs $88.9M），Esperion Therapeutics, Inc.同比增速更快（143.7% vs -1.2%），过去两年Esperion Therapeutics, Inc.的营收复合增速更高（10.6% vs 2.1%）
Esperion Therapeutics, Inc.是一家上市美国药企，专注开发用于降低低密度脂蛋白胆固醇的口服小分子药物苯哌多酸，公司总部位于密歇根州安娜堡，目前核心研发管线围绕这款降脂创新药物推进，深耕血脂异常治疗领域的创新药物开发。
Farmer Bros. Co.是一家总部位于美国得克萨斯州沃斯堡的餐饮服务企业，主打咖啡与茶类产品的生产分销，同时还供应约300种餐厅及其他经营场所所需的餐饮配套用品，目前由约翰·摩尔担任公司首席执行官兼总裁。
ESPR vs FARM — 直观对比
营收规模更大
ESPR
是对方的1.9倍
$88.9M
营收增速更快
ESPR
高出144.9%
-1.2%
两年增速更快
ESPR
近两年复合增速
2.1%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $168.4M | $88.9M |
| 净利润 | — | $-4.9M |
| 毛利率 | — | 36.3% |
| 营业利润率 | 50.6% | -4.7% |
| 净利率 | — | -5.5% |
| 营收同比 | 143.7% | -1.2% |
| 净利润同比 | — | -2417.1% |
| 每股收益（稀释后） | $0.32 | $-0.22 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESPRFARM
| Q4 25 | $168.4M | $88.9M | ||
| Q3 25 | $87.3M | $81.6M | ||
| Q2 25 | $82.4M | $85.1M | ||
| Q1 25 | $65.0M | $82.1M | ||
| Q4 24 | $69.1M | $90.0M | ||
| Q3 24 | $51.6M | $85.1M | ||
| Q2 24 | $73.8M | $84.4M | ||
| Q1 24 | $137.7M | $85.4M |
净利润ESPRFARM
| Q4 25 | — | $-4.9M | ||
| Q3 25 | $-31.3M | $-4.0M | ||
| Q2 25 | $-12.7M | $-4.7M | ||
| Q1 25 | $-40.5M | $-5.0M | ||
| Q4 24 | — | $210.0K | ||
| Q3 24 | $-29.5M | $-5.0M | ||
| Q2 24 | $-61.9M | $-4.6M | ||
| Q1 24 | $61.0M | $-682.0K |
毛利率ESPRFARM
| Q4 25 | — | 36.3% | ||
| Q3 25 | — | 39.7% | ||
| Q2 25 | — | 44.9% | ||
| Q1 25 | — | 42.1% | ||
| Q4 24 | — | 43.1% | ||
| Q3 24 | — | 43.9% | ||
| Q2 24 | — | 38.8% | ||
| Q1 24 | — | 40.1% |
营业利润率ESPRFARM
| Q4 25 | 50.6% | -4.7% | ||
| Q3 25 | -11.4% | -3.9% | ||
| Q2 25 | 8.6% | 4.6% | ||
| Q1 25 | -34.0% | -4.3% | ||
| Q4 24 | -6.4% | 1.1% | ||
| Q3 24 | -31.0% | -3.3% | ||
| Q2 24 | 3.5% | -4.9% | ||
| Q1 24 | 52.5% | -0.5% |
净利率ESPRFARM
| Q4 25 | — | -5.5% | ||
| Q3 25 | -35.9% | -4.9% | ||
| Q2 25 | -15.4% | -5.6% | ||
| Q1 25 | -62.2% | -6.1% | ||
| Q4 24 | — | 0.2% | ||
| Q3 24 | -57.2% | -5.9% | ||
| Q2 24 | -83.9% | -5.4% | ||
| Q1 24 | 44.3% | -0.8% |
每股收益（稀释后）ESPRFARM
| Q4 25 | $0.32 | $-0.22 | ||
| Q3 25 | $-0.16 | $-0.19 | ||
| Q2 25 | $-0.06 | $-0.22 | ||
| Q1 25 | $-0.21 | $-0.23 | ||
| Q4 24 | $-0.14 | $0.01 | ||
| Q3 24 | $-0.15 | $-0.24 | ||
| Q2 24 | $-0.33 | $-0.23 | ||
| Q1 24 | $0.34 | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.9M | $4.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-302.0M | $35.7M |
| 总资产 | $465.9M | $151.4M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ESPRFARM
| Q4 25 | $167.9M | $4.2M | ||
| Q3 25 | $92.4M | $3.8M | ||
| Q2 25 | $86.1M | $6.8M | ||
| Q1 25 | $114.6M | $4.1M | ||
| Q4 24 | $144.8M | $5.5M | ||
| Q3 24 | $144.7M | $3.3M | ||
| Q2 24 | $189.3M | $5.8M | ||
| Q1 24 | $226.6M | $5.5M |
股东权益ESPRFARM
| Q4 25 | $-302.0M | $35.7M | ||
| Q3 25 | $-451.4M | $40.0M | ||
| Q2 25 | $-433.5M | $43.5M | ||
| Q1 25 | $-426.2M | $37.3M | ||
| Q4 24 | $-388.7M | $41.5M | ||
| Q3 24 | $-370.2M | $40.9M | ||
| Q2 24 | $-344.2M | $45.5M | ||
| Q1 24 | $-294.3M | $43.1M |
总资产ESPRFARM
| Q4 25 | $465.9M | $151.4M | ||
| Q3 25 | $364.0M | $158.8M | ||
| Q2 25 | $347.1M | $161.2M | ||
| Q1 25 | $324.0M | $163.2M | ||
| Q4 24 | $343.8M | $179.1M | ||
| Q3 24 | $314.1M | $182.0M | ||
| Q2 24 | $352.3M | $185.2M | ||
| Q1 24 | $373.1M | $179.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $45.2M | $-786.0K |
| 自由现金流经营现金流 - 资本支出 | — | $-2.6M |
| 自由现金流率自由现金流/营收 | — | -2.9% |
| 资本支出强度资本支出/营收 | 0.0% | 2.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ESPRFARM
| Q4 25 | $45.2M | $-786.0K | ||
| Q3 25 | $-4.3M | $-5.0M | ||
| Q2 25 | $-31.4M | $9.7M | ||
| Q1 25 | $-22.6M | $1.3M | ||
| Q4 24 | $-35.0M | $2.6M | ||
| Q3 24 | $-35.3M | $2.5M | ||
| Q2 24 | $-7.2M | $-995.0K | ||
| Q1 24 | $53.8M | $-2.3M |
自由现金流ESPRFARM
| Q4 25 | — | $-2.6M | ||
| Q3 25 | — | $-6.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-684.0K | ||
| Q4 24 | — | $521.0K | ||
| Q3 24 | $-35.5M | $-837.0K | ||
| Q2 24 | $-7.3M | — | ||
| Q1 24 | $53.8M | $-5.7M |
自由现金流率ESPRFARM
| Q4 25 | — | -2.9% | ||
| Q3 25 | — | -8.5% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.8% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | -68.7% | -1.0% | ||
| Q2 24 | -9.9% | — | ||
| Q1 24 | 39.0% | -6.7% |
资本支出强度ESPRFARM
| Q4 25 | 0.0% | 2.1% | ||
| Q3 25 | 0.0% | 2.4% | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | 2.4% | ||
| Q4 24 | 0.0% | 2.3% | ||
| Q3 24 | 0.3% | 3.9% | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | 4.0% |
现金转化率ESPRFARM
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 12.16× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
FARM
| Coffee Roasted | $45.5M | 51% |
| Tea Iced Hot | $23.3M | 26% |
| Culinary | $14.1M | 16% |
| Spice | $4.9M | 5% |
| Fuel Surcharge | $1.2M | 1% |
